American Healthcare REIT, Inc. (AHR) Valuation
Historical valuation analysis based on 500 data points (2024-09-23 to 2026-09-21)
American Healthcare REIT Inc is a healthcare-focused real estate investment trust. It owns a diversified portfolio of clinical healthcare real estate properties, focusing on medical office building...
American Healthcare REIT, Inc. (AHR) currently trades at a P/E ratio of 97.99 (historical range: 85.63–325.58, median: 242.41), placing it at the 26th percentile — below its historical average, P/S ratio of 4.46 (range: 1.63–4.92, 89th percentile — expensive relative to its history).
American Healthcare REIT, Inc. appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels.
Historical Valuation Metrics
| Metric | Current | Min | Median | Max | Percentile | Assessment |
|---|---|---|---|---|---|---|
| P/E Ratio | 97.99 | 85.63 | 242.41 | 325.58 | 26th | below its historical average |
| P/S Ratio | 4.46 | 1.63 | 3.26 | 4.92 | 89th | expensive relative to its history |
American Healthcare REIT, Inc. (AHR) Valuation & P/E History
American Healthcare REIT, Inc. (AHR) is a US-listed stock operating in the Real Estate sector, specifically the Real Estate Investment Trusts industry currently trading at $52.30 with a market capitalization of $11.4 billion. This page provides historical valuation analysis for AHR based on 500 data points covering 2024-09-23 to 2026-09-21. The P/E ratio of 97.99 is below the historical median of 242.41, placing AHR at the 26th percentile of its valuation range. The P/S ratio of 4.46 compares to a median of 3.26.
AHR Valuation Metrics & Historical Range
The valuation table above shows American Healthcare REIT, Inc.'s current and historical valuation multiples, including P/E ratio, P/S ratio, EV/EBITDA, FCF yield, and dividend yield. Each metric is compared to its own historical range to determine whether AHR is currently trading above or below its typical valuation levels.
- P/E ratio: Price-to-earnings measures how much investors pay per dollar of earnings. A P/E above the historical median suggests AHR is expensively valued; below the median suggests it is cheap.
- P/S ratio: Price-to-sales is useful for companies with volatile or negative earnings. Lower P/S relative to history may indicate value.
- EV/EBITDA: Enterprise value to EBITDA adjusts for debt and cash, providing a capital-structure-neutral valuation measure for American Healthcare REIT, Inc..
- FCF yield: Free cash flow yield shows the cash return relative to market price. Higher yields may indicate undervaluation.
Is AHR Overvalued or Undervalued?
American Healthcare REIT, Inc. appears slightly overvalued relative to its historical range, with most valuation metrics above their median levels. The overall valuation percentile of 58 combines P/E, P/S, and EV/EBITDA percentiles into a single measure of how expensive AHR is relative to its own history. A percentile below 25 suggests the stock may be undervalued, while a percentile above 75 suggests it may be overvalued.
However, valuation is only one factor in investment decisions. A stock can remain "overvalued" for years if growth accelerates, or "undervalued" if the business deteriorates. Always combine valuation analysis with financial statement analysis and the full AHR analysis page for a complete picture.
Valuation data is computed from historical price and fundamental data via Polygon.io and Finnhub.AHR trades on NYSE/NASDAQ. This page is for informational purposes only and is not financial advice.